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Abstract
Natural killer (NK) cells serve as a crucial first line of defense against tumors, viral and bacterial infections. We studied the
involvement of a principal activating natural killer cell receptor, natural cytotoxicity receptor 1 (NCR1), in the innate immune
response to S. pneumoniae infection. Our results demonstrate that the presence of the NCR1 receptor is imperative for the
early clearance of S. pneumoniae. We tied the ends in vivo by showing that deficiency in NCR1 resulted in reduced lung NK
cell activation and lung IFNc production at the early stages of S. pneumoniae infection. NCR1 did not mediate direct
recognition of S. pneumoniae. Therefore, we studied the involvement of lung macrophages and dendritic cells (DC) as the
mediators of NK-expressed NCR1 involvement in response to S. pneumoniae. In vitro, wild type BM-derived macrophages
and DC expressed ligands to NCR1 and co-incubation of S. pneumoniae-infected macrophages/DC with NCR1-deficient NK
cells resulted in significantly lesser IFNc levels compared to NCR1-expressing NK cells. In vivo, ablation of lung macrophages
and DC was detrimental to the early clearance of S. pneumoniae. NCR1-expressing mice had more potent alveolar
macrophages as compared to NCR1-deficient mice. This result correlated with the higher fraction of NCR1-ligand
high lung
macrophages, in NCR1-expressing mice, that had better phagocytic activity compared to NCR1-ligand
dull macrophages.
Overall, our results point to the essential contribution of NK-expressed NCR1 in early response to S. pneumoniae infection
and to NCR1-mediated interaction of NK and S. pneumoniae infected-macrophages and -DC.
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Introduction
The gram positive bacterium Streptococcus pneumoniae belongs to
the commensal flora of the human respiratory tract. However S.
pneumoniae also causes clinical infections including pneumoniae,
meningitis and sepsis [1]. Pneumococcus is the fifth leading cause
of death worldwide [2]. Considering the spread of antibiotic
resistance to the bacterium, it is crucial to understand the host
response to pneumococcal infection in order to improve therapy.
The host immune response to pneumococcal lung disease has
been characterized as an intense inflammatory reaction, initially
involvingresident alveolar and interstitial macrophages, followed by
lung infiltrating neutrophils [2]. Yet, the contribution of immune
components, other than phagocytic cells, has also been demon-
strated to be important [3–6]. It has emerged that chemokines and
pro-inflammatory cytokines such as tumor necrosis factor alpha
(TNFa), interleukin (IL)-6 and IL-1b have a crucial role in defense
against S. pneumoniae. These mediators recruit and activate
inflammatory cells to the site of infection. Several studies, including
our own, showed that depletion or genetic ablation of these
cytokines resulted in impaired host defense [7–9]. Interferon
gamma (IFNc) is another critical immunomodulator in early host
defense against a variety of infections. IFNc is a key activator of
macrophage killing activity and also recruits circulating neutrophils
andlymphocytestothe sitesofinfection.The roleofIFNcinnatural
immunity to S. pneumoniae infection is not clear as reports are
contradictive [10–12]. Natural killer (NK) cells are bone marrow
derived lymphocytes that constitute a key frontline defense against a
wide range of pathogens such as viruses, bacteria, intracellular
parasites [13–15], as well as tumors [16]. NK cells are believed to
release the prominent fraction of the IFNc evident during Gram-
positive infection [17] and they are recruited to the lung during
pneumococcal pneumoniae within 6 hours of infection [18].
Although NK cells can kill target cells spontaneously without prior
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receptors tightly regulate their activation. Among these, natural
cytotoxicity receptor-1 (NCR1, also named NKp46) is the only
receptor reported so far to be expressed specifically on NK cells in
all mammals tested, including humans [19] and mice [20]. NKp46
is a transmembrane type i glycoprotein containing two immuno-
globulin domains and positively charged arginine residue in the
transmembrane domain, which associates with the CD3f or the
FceRIc signaling adaptor molecules [19,21] . Several in vitro studies
have demonstrated that NKp46 is important in the recognition and
destruction of various tumors [16,22] and virus infected cells
[23,24]. In addition, we have recently demonstrated a critical
function for murine NCR1 (murine NKp46) in the in-vivo
eradication of influenza virus [25]. There are contradicting reports
about the role of NK cells and IFNc in pneumococcal infections,
thus their exact effect is not yet defined. Rubins et al. showed that
IFNc
-/- mice demonstrated increased mortality during S. pneumoniae
lung infection, suggesting a protective role for IFNc in host response
to pneumococcal disease [10]. In contrast, Rijneveld et al. demon-
strated that IFNc does not serve a protective role during
pneumococcal pneumonia. IFNcR
-/- mice and IFNc
-/- mice had
relatively increased resistance to S. pneumoniae infection, exhibiting
significantly fewer pneumococci in their lungs in comparison to wild
type (WT) mice [11]. NK cells were shown to be detrimental in
pneumococcal pneumonia and sepsis in immunocompromised mice;
depletion of NK cells in SCID mice resulted in significantly lower
bacteremia and inflammatory cytokine production [26]. In this
present study we employed C57BL/6 mice in which a gene
encoding GFP was inserted into the Ncr1 locus, thereby rendering
the Ncr1 gene nonfunctional. Using these mice we assessed the
involvement of the NCR1 receptor in the activation of NK cells
following S. pneumoniae infection, and the role of NCR1 in the
reciprocal interaction between NK cells, DC and macrophages
following S. pneumoniae infection. The involvement of NCR1 was
shown to contribute to NK cellactivation together with S. pneumoniae
clearance at early stages following inoculation.
Materials and Methods
Mice
C57BL/6 mouse strain Ncr1
gfp/gfp, Ncr1
+/gfp and Ncr1
+/+ wild
type littermates were used. In these mice, as described previously
[25],the geneencodingtheNCR1receptor(Ncr1)wasreplacedwith
a green fluorescent protein (GFP) reporter cassette. This study
involved also the use of the C57BL/6 mouse strain CD11c:
Diphtheria toxin (DTx) receptor (DTR) transgenic mice (B6.FVB-
Tg (Itgax-DTR/GFP)57Lan/J; The Jackson Laboratory) that carry
a human DTR transgene under the murine CD11c promoter [27].
All experiments were done in the animal facilities of Ben Gurion
University according to guidelines of the ethical committee.
Bacteria
The S. pneumoniae strain WU2 (capsular serotype 3) was used in
this study [28]. This strain was grown to mid-late log phase as
determined by OD in Todd-Hewitt broth supplemented by yeast
extract. Aliquots of bacteria were harvested by centrifugation, re-
suspended in sterile PBS containing 10% glycerol and stored at
270uC. Colony-forming units (CFU) counts were verified in each
experiment on blood agar plates at 37uC under microaerobic
conditions.
Infection of mice with S. pneumoniae
For mice infection, aliquots of bacteria were thawed rapidly and
samples of serial 10-fold dilutions were plated onto blood agar
plates for determining bacterial concentration. Each mouse was
anaesthetized with Terrel isoflurane (MINRAD, New York, USA)
and inoculated intranasally with 5610
7,1 610
8 or 4610
8 bacteria
(in 25 ml PBS). Survival was monitored daily until 8 days after
inoculation.
Determination of bacterial load in the nasopharynx and
lungs
Mice were sacrificed by Terrel isoflurane inhalation at 3, 6 and
24 h after inoculation. Nasopharynx and lungs were removed and
homogenized in 1 ml of sterile PBS using the Polytron PT-10
homogenizer (Kinematika, Lucerne, Switzerland). Samples (25 ml)
in serial dilutions were then plated onto blood agar plates and
grown overnight (18 h) at 37uC in anaerobic jars for CFU
determination.
Real time PCR
Total RNA was extracted from C57BL/6 mice lungs by TRI-
Reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Purified RNA was converted to
cDNA utilizing Promega’s First Strand Synthesis (Madison, WI,
USA). 20–100 ng RNA was subsequently used as a template for
each Real-Time-PCR reaction. All PCR reactions for cytokine-
specific mRNA were preformed on ABI PRISM 7500 Real-Time
PCR System (ABI Applied Biosystems, USA) using proprietary
cytokine-specific primers from ABI Applied Biosystems, USA.
Relative cytokine mRNA levels were determined by normalization
of signal with that for GAPDH mRNA. In initial studies, fivefold
dilutions of cDNA generated a linear signal curve over at least a
30-fold range of cDNA concentrations. mRNA induction in pulsed
lung tissue was reported as-fold increases over uninfected lung
mice. We thank Mr. Shahar Dotan (Ben Gurion University of the
Negev, Beer-Sheva, Israel) for supplement of the primers.
Depletion of CD11c
+ cells following Intratracheal (i.t.)
instillation of DTx
PBS (80 ml) containing DTx (100 ng/gr, List Biological
Laboratories) was applied to the mouse tracheae. Mice were
lightly anesthetized using isoflurane and placed vertically and their
tongues were pulled out. Using a long nasal-tip, liquid was placed
at the top of tracheae and was then actively aspirated by the
mouse. Gasping of treated mice verified liquid application to the
alveolar space.
Cell isolations and generation of Bone Marrow Derived
DCs/Macrophages
For bronchoalveolar lavage (BAL), the trachea was exposed to
allow insertion of a catheter, through which the lung was filled and
washed 10 times with 5 ml of PBS without Ca
2+/Mg
2+. Bone
marrow (BM)-derived DC (BMDC) and bone marrow (BM)-
derived macrophages (BMMQ) were generated from Bone
marrow which obtained from C57BL/6 mice by flushing femoral
cells with a 23-gauge needle with RPMI. Low-density mononu-
clear bone marrow cells were isolated using red blood cell lysing
buffer (SIGMA) and centrifuged. Cells (5610
6) were cultured in
10 cm tissue dishes with the fresh complete Iscove’s Modified
Dulbecco’s Medium (cIMDM) with recombinant GM-CSF
(100 ng/ml) or 20% Lymphocyte conditioned medium (LCM)
respectively. The medium was changed every 2–3 days and
replaced with fresh medium supplemented with GM-CSF
(100 ng/ml) or 20% LCM respectively. For experiments, the
slightly adherent cells (DC) and/or the adherent cells (macro-
phages) were harvested on days 6 to 8 of culture.
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from RBC using the ACK lysing buffer (Quality Biological, Inc.,
Gaithersburg, MD). NK cells were then negatively selected by
EasySep NK Selection Kit (StemCell Technologies, Inc., Van-
couver, Canada). The percentage of NK cells in the isolated
population was evaluated using PE-conjugated anti-CD3 mAb
and APC-conjugated anti-CD56 or anti-NK1.1 mAb (eBioscience)
by flow cytometry. Recombinant IL-2 (100 IU/ml) was added in
order to obtain a polyclonal NK cell population.
Antibodies and Flow cytometry
Flow cytometry analysis was employed for analysis of cell surface
marker expression. Splenocytes, total lung cells, BM cells (1610
6
per well) or bronchoalveolar lavage fluid (BALF) cells (0.5610
6 per
well) were plated in 96-well U-bottom plates. Cells werewashedand
non specific binding was blocked with anti-CD16/CD32 in 0.5%
FCS/0.5% mouse serum/PBS for 15 min on ice. Cells were then
stained for 25 min with the following specific mAbs: Biotin-
conjugated-anti-mF4/80, FITC-anti-mCD45, PE-anti-mNK1.1,
PE-anti-mCD69, PE-anti-mCD115, PE-anti-mCD3, PE-anti-
mCD11b, PercpCy5.5-anti-mCD11c, Pacific Blue-anti-mCD11b,
Alexa flour 647-anti-mCD107a, APC-anti-NK1.1, APC-anti-
mCD3, APC-anti human Fc-IgG, APC-conjugated streptavidin,
all purchased from eBioscience. For staining with fusion-Igs, cells or
bacteria were incubated with 4 or 2 mg of the mNCR1-Ig,
mNKG2D-Ig, LIR1-Ig or CD99-Ig fusion proteins for 2 h at
4uC, washed, and stained with APC-conjugated-F(ab’)2 goat-anti-
human-IgG-Fc (109-136-098, minimal cross-reaction to bovine,
horse and mouse serum proteins, Jackson Immuno Research, West
Grove, PA). Staining and washing buffer consisted of 0.5% (w/v)
BSA and 0.05% sodium azide in PBS. Propidium iodide or
AmCyan dye was added prior to reading for exclusion of dead cells.
Stained cells were analyzed using either FACSCalibur or
FACSCanto II (Becton Dickinson, Mountain View). The data were
then analyzed either with BD CELLQuest
TM 3.3 software or
FlowJo software version 6.3.4 (Tree Star). Fluorescence data was
acquired using logarithmic amplification and reported fluorescence
intensity units represent conversion of channel values according to
the logarithmic scale (range 10
0 to 10
4). Results are shown as the
geometric mean fluorescence intensity (MFI) of the stained
populations.
NK/BMDC and NK/BMMQ co-cultures
NK cells and BMDC or BMMQ co-cultures were preformed in
RPMI 1640 +10% FCS in 24 well plates. Live S. pneumoniae were
added to BMDC/BMMQ cultures (10
6 cells /well) for 1.5 h at
noted multiplicity of infection (MOI) ratio. NK cells were added to
BMDC (1:10) or BMMQ (1:4) cultures 5 hours after infection
followed by bacterial washing with Tetramycin (30 mg/ml),
Gentamycin (50 mg/ml), Penicillin (100 U/ml) and Streptomycin
(100 mg/ml). After additional incubation for 24 h cells were
collected and analyzed.
ELISA for IFNc in supernatant
The concentration of IFNc secreted into the media of BMDC/
BMMQ cultures was measured using optimized standard
sandwich ELISA. Media samples were centrifuge at 1200 rpm
for 10 min and supernatant was collected and stored in -70uC.
Recombinant mouse IFNc (mIFNc) which was used as standard,
as well as the capture mAb, biotinylated mAb which was used for
detection, and Streptavidin-HRP were purchased from BD-
PharMingen. The samples were tested in triplicates. The concen-
tration of the cytokine was determined relative to a standard curve
of recombinant IFNc (ranging from 10,000 pg/ml to 125 pg/ml
at 1:2 serial dilutions).
Depletion of NK cells following intraperitoneal
administration of anti-asialo GM1
NK cells were depleted using polyclonal anti-asialo-GM1 rabbit
antibody (Wako Bioproducts, Neuss, Germany). Mice were
injected with 50 ml of anti asialo-GM1 in 200 ml of PBS or with
equivalent volume of PBS 24 h prior to intranasal infection with S.
pneumoniae. 27 hours post-infection the lung and spleen were
collected and subjected to a CFU assay and to FACS staining in
order to check the efficacy of treatment.
CFDA staining of bacteria
Bacteria were grown to mid-late log phase as determined by
OD in Todd-Hewitt broth supplemented by yeast extract. Aliquots
of bacteria were harvested by centrifugation (13000 rpm), re-
suspended in sterile PBS and washed twice. Bacteria (1 ml
suspension, 1*10
6 cell concentration) were then stained with
carboxyfluorescein diacetate (CFDA) using 200 ml of stock solution
(0.5 mM), incubated with shaking for 30 min in 37uC, and washed
twice following incubation.
Immunocytochemistry
BALF cells were grown on chamber m-slide (Ibidi, Germany),
incubated alone or with 1 MOI CFDA-labeled S. pneumonia for
1 hour. Cells were then rinsed with PBS, fixed for 10 minutes in
2% paraformaldehyde and blocked with PB/A blocking solution
(PBSX1, 5% BSA, 0.5%NaN3) for 30 minutes. Fixed cell were
stained with mNCR1-Ig and rat anti mouse F4/80-biotin
conjugated. Secondary staining was made using APC-conjugat-
ed-F(ab’)2 goat-anti-human-IgG-Fc and PE-Cy7-Strepavidin.
Nuclear staining was made using Hoechst 33342 1:10000 (Fluka,
Switzerland). All incubations were made in room temperature. All
antibodies were diluted in PB/A. After each step the wells were
rinsed for three times. Images acquisition and analysis were made
using either Olympus IX70 fluroscentic microscope or Olympus
Fluoview 1000 Laser Scanning Microscopy system equipped with
a 40x/1.3 oil immersion objective.
Statistical analysis
Results obtained from groups of 3 to 12 mice were expressed as
the mean 6SD. Mann-Withney U-test analysis was used.
Differences in the number of bacterial loads in the lungs were
analyzed by using two-tailed Student’s t test. Differences in cells
number between two groups were analyzed by using two-tailed
Student’s t test or by one-way ANOVA. Values for p,0.05 were
considered to be statistically significant.
Results
Survival of Ncr1
gfp/gfp, Ncr1
+/gfp and Ncr1
+/+ mice
following intranasal challenge with S. pneumoniae
We first aimed to evaluate the influence of deficiency of the
activating natural killer cell receptor gene, Ncr1, on the survival of
mice after infection with S. pneumoniae. C57BL/6 Ncr1
gfp/gfp, Ncr1
+/
gfp and Ncr1
+/+ WT littermate mice were infected with high lethal
dose (4610
8)o fS. pneumoniae serotype 3 strain WU2 and survival
was monitored for 8 days (Fig. 1). The survival rate of Ncr1
gfp/gfp
was significantly lower than Ncr1
+/+ mice (p,0.05). The Ncr1
+/gfp
shows the same pattern of survival as Ncr1
+/+ but is not
significantly different from the survival rate of Ncr1
gfp/gfp mice
due to small number of mice. Challenging the mice with 1610
8 or
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7 of S. pneumoniae resulted in similar survival rate for all 3
mice groups (data not shown). These data suggest that the NCR1
receptor plays an important role in the survival of mice only
following challenge with high dose of S. pneumoniae.
Bacterial load in lungs of Ncr1
gfp/gfp, Ncr1
+/gfp and Ncr1
+/+
mice following intranasal challenge with S. pneumoniae
We next assessed the importance of the NCR1 receptor in the
clearance of S. pneumoniae from the lungs at the early stages
of infection. We compared the bacterial load in this organ of
Ncr1
gfp/gfp, Ncr1
+/gfp and Ncr1
+/+ mice, at 3, 6 and 24h after
intranasal inoculation with 5610
7 S. pneumoniae strain WU2 (Fig. 2).
In accordance with the survival results, 24 h after inoculation, the
bacterial load in the lungs of Ncr1
gfp/gfp mice was comparable to
the levels observed in the lungs of Ncr1
+/+ and Ncr1
+/gfp mice
(Fig. 2C). In sharp contrast, during the first 6 hours of infection,
the bacterial load in the lungs of Ncr1
gfp/gfp mice was significantly
higher than in Ncr1
+/+ and Ncr1
+/gfp mice (Fig. 2A, 2B, p,0.01).
The number of bacteria in the lungs of Ncr1
+/+ and Ncr1
+/gfp mice
was similar during all the above-described time points (Fig. 2A–C).
This is in accordance with the observation that NK cells from
Ncr1
+/gfp mice are fully competent [25]. Overall, bacterial load
numbers in the lungs of Ncr1
+/+ and Ncr1
+/gfp mice increased 5.7
fold in average between 3 to 24 h post challenge, while for Ncr1
gfp/
gfp mice the average fold increase was only 1.7. These data suggest
that the NCR1 receptor plays an important role in mediating the
clearance of S. pneumoniae in the lungs early after infection.
Contribution of NCR1 to NK cells activation by
S. pneumoniae
To further investigate the NCR1-dependent activation of NK
cells following S. pneumoniae infection, we studied activation of NK
cells and IFNc production in the lungs 3 h following intranasal
challengewith the bacteria.EnhancementofCD107aexpressionon
NK cell membranes represents the fusion of secretory granules with
the plasma membrane and not de-novo protein synthesis. Therefore,
CD107a enhancement is a marker for NK cell activation at early
stages reflecting cytokine secretion and release of the content of lytic
granules [29]. In vivo, 3 h following S. pneumoniae challenge,
membrane-associated expression of CD107a by lung NK cells
appeared in both Ncr1
+/gfp and Ncr1
gfp/gfp mice compared to
uninfected mice (p,0.05 for both, Fig. 3A). Yet, this increase was
significantly higher in lung NK cells from NCR1-expressing mice
(Ncr1
+/gfp) compared to NCR1-deficient mice (Ncr1
gfp/gfp) (52% vs.
28%, p,0.01, Fig. 3A). NK cell number in lungs of infected mice
didn’t differ between Ncr1
+/gfp and Ncr1
gfp/gfp (data not shown).
To assay local IFNc production in vivo, total RNA was extracted
from lungs of naı ¨ve and 3 h-infected Ncr1
+/gfp and Ncr1
gfp/gfp mice.
IFNc mRNA was quantified by real-time PCR. In accordance
with the CD107a levels (Fig. 3B), IFNc transcript in 3 h-infected
lungs increased considerably compared to non-infected lungs for
both Ncr1
+/gfp and Ncr1
gfp/gfp mice (Fig. 3B). Yet, the fold
increment of IFNc was significantly higher in NCR1-expressing
mice compared to NCR1-deficient mice (Fig. 3B, p,0.01).
Challenge with S. pneumoniae induces a local production of
Figure 1. Survival of mice after intranasal inoculation with
S. pneumoniae. (A) Ncr1
+/+ (WT, n=13), Ncr1
+/gfp (Het, n=6) and
Ncr1
gfp/gfp (KO, n=12) C57BL/6 mice were challenged intranasally with
high lethal dose of S. pneumoniae strain WU2 in 25 ml PBS. Survival was
monitored daily for 8 days. Results are the summary of two
independent experiments. Statistical analysis revealed significant
differences in survival rates between Ncr1
+/+ and Ncr1
gfp/gfp mice, while
Ncr1
+/+ mice had higher survivel rate (*p,0.05, two-tailed Mann-
Withney U-test, line is for geometric mean).
doi:10.1371/journal.pone.0023472.g001
Figure 2. Bacterial load in lungs. Ncr1
+/+ (WT), Ncr1
+/gfp (Het) and Ncr1
gfp/gfp (KO) C57BL/6 mice were challenged intranasally with 5610
7
concentration of S. pneumoniae strain WU2. Lungs were harvested for CFU assessment: (A) 3 h after inoculation (n=6 to 8), (B) 6 h (n=5 to 9), and (C)
24 h (n=5 to 6). Results are the summary of 3 independent experiments and were normalized according to the CFU of the Het group that its CFU
average was considered as 1 in each experiment. ** p,0.01, compared with WT or with Het groups 6SD (two-tailed student t-test). NS, not
significant compared with WT or with Het groups. Results are presented as vertical scatter plot of normalized CFU.
doi:10.1371/journal.pone.0023472.g002
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whether the observed differences in 3 h following challenge
bacterial load could correlate with differential induction of other
proinflammatory cytokines. TNFa and IL-6 mRNA levels were
quantified. Similarly to the IFNc, TNFa and IL-6 transcripts in
the lung were greatly induced 3 h following challenge (Fig. 3C, D).
However, the opposite trend to IFNc results was observed when
comparing between NCR1-expressing and -deficient mice; fold
increase was significantly higher in Ncr1
gfp/gfp mice (Fig. 3C, D,
p,0.001). This data suggest that the NCR1 receptor plays an
important role in activation of NK cells during early stages of S.
pneumoniae infection by activating IFNc production and enhancing
CD107a expression.
Bacterial load in the lungs of NK-depleted mice following
intranasal challenge with S. pneumoniae
To validate the role of NK cells in mediating early clearance of
S. pneumoniae in the lungs, we depleted NK cells using anti-asialo
GM1 (one injection of 50 ml per mouse). More than 95% of NK
cells were removed following depletion as tested 24 h later (Fig. 4B,
shown for both Ncr1
gfp/gfp and Ncr1
+/+ groups). Twenty-four hours
following NK cell depletion or mock treatment, we challenged
Ncr1
gfp/gfp and Ncr1
+/+ mice with 5610
7 CFU S. pneumoniae strain
WU2 and compared the bacterial load in the lungs 3 h later
(Fig. 4A). In both mice groups, depletion of NK cells 24 h prior to
infection resulted in a significant increase of bacterial load 3 h
following inoculation compared to the mock-treated mice (3.8 and
2.57 fold increase, p,0.01 and p,0.05 for Ncr1
+/+ and Ncr1
gfp/gfp,
respectively). These results point to the involvement of NK cells in
early clearance of S. pneumoniae challenge. As expected (Fig. 4A),
3 h after inoculation, bacterial load in mock-treated Ncr1
gfp/gfp was
significantly higher compared to mock-treated Ncr1
+/+ mice (4.4
fold increase, p,0.01). Increased bacterial load was also observed
between NK-depleted Ncr1
gfp/gfp and NK-depleted Ncr1
+/+ mice,
yet to a lower extent (2.9 fold, p,0.05). This indicates that in
addition to NK cells contribution to early clearance upon
Figure 3. NK cells activation and cytokines mRNA levels in lungs following intranasal challenge with S. pneumoniae. Lungs were
harvested from Ncr1
+/gfp (Het group) and Ncr1
gfp/gfp (KO group) C57BL/6 mice 3h after intranasal inoculation with 5610
7 CFU of S. pneumoniae strain
WU2, and from non infected mice. (A) NK cells were gated as CD45
+NK1.1
+ and analyzed for the expression of membrane-associated CD107a by flow
cytometry. The bar graphs show the fraction of CD107a positive NK cells (average of 3 mice per group, 6SD). ** p,0.01 compared to Het group in
3h-infected mice (ANOVA test). Total RNA was extracted from naı ¨ve lungs and from 3h-infected lungs of Ncr1
+/gfp (Het) and Ncr1
gfp/gfp (KO). Infection
was performed with 5610
7 CFU of S. pneumoniae. Level of cytokines mRNA of IFNc (n=4), TNFa (n=4) and IL-6 (n=3) were analyzed by RT-PCR and
calibrated to mRNA level of GAPDH. Results are from one representative experiment of two. *** p,0.001, ** p,0.01, compared with the Het group
+SD (ANOVA test).
doi:10.1371/journal.pone.0023472.g003
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+/+ mice, e.g. phagocytes, might be
better conditioned to cope with S. pneumoniae infection at early
stages.
Bacterial load in the macrophage/ DC-depleted lungs
following intranasal challenge with S. pneumoniae
To assay in vivo the contribution of lung phagocytes to S.
pneumoniae clearance at early stages following infection, the extent
of bacterial load in Ncr1
gfp/gfp, Ncr1
+/gfp and mice ablated from
lung CD11c
+ mononuclear phagocytes was compared. We took
advantage of CD11c:DTR transgenic mice that allow a specific
depletion of CD11c
high cells [27]. The intratracheal DTx
installation into CD11c:DTR transgenic mice results in the
specific local ablation of CD11c
+ lung mononuclear phagocytes,
including macrophages and DC [27] (Fig. 5B). Mice were
inoculated with 5610
7 S. pneumoniae serotype 3 strain WU2, and
we assessed the number of bacteria in the lungs DTx- and mock-
treated CD11c: DTR mice, Ncr1
+/gfp and Ncr1
gfp/gfp mice 3 h after
inoculation (Fig. 5A). The bacterial load in the lungs of DTx-
treated CD11c: DTR mice was significantly higher than the load
in the lungs of mock-treated CD11c: DTR mice (p,0.001), and
was similar to that of mock-treated Ncr1
gfp/gfp mice. DTx-treated
and mock-treated Ncr1
+/gfp mice had low bacterial load similar to
that of mock-treated CD11c:DTR mice. Fold increase between
mock-treated and DTx-treated CD11c: DTR mice was similar to
that between mock-treated Ncr1
+/gfp and Ncr1
gfp/gfp (6 fold
increase, p,0.01). Thus, lung CD11c
+ mononuclear phagocytes
play a major role in the clearance of S. pneumoniae inoculated
intranasally.
NCR1 involvement in NK cells activation following
infection of bone marrow-derived macrophages and
bone marrow-derived DC with S. pneumoniae
We studied the expression of ligands to NCR1 by BMMQ and
BMDC. We stained BMMQ and BMDC from 6-day cultures with
mNCR1-Ig and mNKG2D-Ig fusion proteins. Human protein
LIR1-Ig served as negative control for the staining. F4/
80
+CD115
+ BMMQ and CD11c
+ BMDC were stained positively
with the mNCR1-Ig (Fig. 6A–D) and mNKG2D-Ig (Fig. 6C–D).
The positive staining was specific, as no staining was observed with
the control fusion protein LIR1-Ig (Fig. 6A–B). These results imply
that macrophages and DC are able to express ligands to NCR1
and could be involved in the innate immune response of NCR1
+/+
mice to S. pneumoniae challenge. We then investigated whether S.
pneumoniae-infected BMMQ or BMDC could activate NK cells via
the NCR1 receptor; we studied IFNc levels in the co-cultures of
BMMQ/BMDC from WT mice with NK cells from NCR1-
expressing and NCR1-deficient isolated NK cells. In brief, WT
BMMQ/BMDC from 6-day culture were infected with S.
pneumoniae for 1.5 hr, then bacteria were washed and antibiotics
were added; Infected BMMQ/BMDC were then co-cultured with
NK cells from either Ncr1
+/+ or Ncr1
gfp/gfp C57BL/6 mice for
18 hrs and IFNc levels in the supernatant were assayed.
IFNc levels were zero to negligible for NK cell cultures without
BMMQ/BMDC even in the presence of S. pneumoniae (Fig. 6E–F,
‘SP’). Similarly, no IFNc was detected when NK cells were co-
cultured with non-infected BMMQ/BMDC (Fig. 6E–F, ‘BMMQ’,
‘BMDC’). Co-cultures of Ncr1
gfp/gfp-derived NK cells with WT
BMMQ/BMDC contained IFNc, yet significantly less than IFNc
Figure 4. Bacterial load in lungs following in vivo depletion of NK cells. Ncr1
+/+ and Ncr1
gfp/gfp C57BL/6 mice treated intraperitoneally either
with 50 ml of anti asialo GM1 (WT-anti NK and KO-anti NK) or with 50 ml of PBS (mock treatment, WT-mock and KO-mock). 24 h after anti asialo GM1
or mock treatment, all mice were challenged with 5610
7 CFU of S. pneumoniae strain WU2 and lungs were harvested 3 h after challenge. (A) CFU of S.
pneumoniae in lungs, 3 h after bacterial challenge (n=3 to 5 per group). Results are presented as box plot of CFU. ** p,0.01 compared with WT-
mock; * p,0.05, compared with WT-anti NK, 6 SD (ANOVA test). (B) Flow cytometry analysis of spleen cells from depleted and non-depleted mice for
CD3 negative-gated cell population showing NK1.1 versus GFP expression. Analysis was made 24 h after depletion and 3 h following bacterial
challenge (representative mouse per each panel). Numbers indicate percentage of gated cells (LR+UR) from CD3
2 cells. Results are from one
representative experiment of two.
doi:10.1371/journal.pone.0023472.g004
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+/+-derived NK cells with WT
BMMQ/ BMDC (p,0.01, Fig. 6E–F ‘BMMQ+SP’, ‘BMDC+SP’).
To summarize, these results indicate a significanceof NCR1 for NK
cell activation following the cross-talk with S. pneumoniae-infected
BMMQ and BMDC.
NCR1 ligand expression on macrophages and DC
To further investigate NK cell-expressed NCR1 involvement in
S. pneumoniae, we first tested whether NCR1 ligands are expressed
by the bacteria. A recent study suggested that NKp44 on human
NK cells may be involved in the direct recognition of bacterial
pathogens [31]. To investigate whether NCR1 could interact
directly with the bacterium, we stained S. pneumoniae with soluble
mNCR1-Ig and mNKG2D-Ig fusion proteins. Both proteins did
not stain S. pneumoniae indicating that neither NKG2D- nor
NCR1-ligands are expressed on the bacteria (Fig. 7A). These
results imply that the involvement of NCR1 in S. pneumoniae
infection could be indirectly mediated via the interaction of NK
cells with NCR1 ligand-expressing macrophages or DC. The
importance of the lung macrophage response during infection with
S. pneumoniae implied from Fig. 5, and knowing that macrophages
comprise 98% of lung lavage (BAL) leukocytes cells, led us to
investigate the phenotypic characterization of macrophages in
lung BAL and whether the presence of the NCR1 receptor in mice
plays a role in this phenotype. Cells from lung BAL, BM and
spleen were harvested from Ncr1
+/+, Ncr1
+/gfp and Ncr1
gfp/gfp naı ¨ve
C57BL/6 mice and stained with mNCR1-Ig and mNKG2D-Ig
for detection of their ligands. Human fusion proteins LIR1-Ig and
CD99-Ig served as negative staining controls. Staining with
mNCR1-Ig of lung BAL showed two different sub-populations:
F4/80
+CD115
+NCR1-ligand
high and F4/80
+CD115
+NCR1-ligand
dull
(Fig. 7B). Similarly, staining of BM F4/80
+CD115
+ macrophages
also revealed the NCR1-ligand
high and NCR1-ligand
dull sub-
populations (Fig. 7C). The NCR1-ligand
high macrophage sub-
population was significantly higher in BAL and BM of Ncr1
+/+
compared to Ncr1
gfp/gfp (2 fold, P,0.001, Fig. 7E); likewise, it was
higherin lung and BM of Ncr1
+/gfp compared to Ncr1
gfp/gfp(1.4 fold,
P,0.05, Fig. 7F). The results in panels 7E-F represent normalized
values as the actual fraction of NCR1-ligand
high macrophage
sub-population varied between experiments and mice and ranged
between 5% to 25% for Ncr1
+/+ mice. Yet, it was significantly lower
in lung BAL and BM of Ncr1
gfp/gfp mice (Fig. 7E–F). Notably, the
NCR1-ligand
high BAL macrophages had higher expression of
CD115 and residual staining with LIR1-Ig that might point to
high expression of Fc receptors though the blocking of those
receptors during staining (see Methods). The staining of macro-
phages from spleen did not reveal the NCR1-ligand
high sub-
populationinanyofthethree mice types(Fig.7D).Weobservedthis
direct correlation between NCR1 presence and NCR1-ligand
high
macrophage sub-population in additional genetic backgrounds of
Figure 5. Bacterial load in lungs following in vivo ablation of lung CD11c
+ cells. CD11c:DTR mice (C57BL/6 genetic background) were
treated intratracheally with DTx (100 ng/gr, DTR-tox group). CD11c:DTR littermates treated intratracheally with PBS (‘DTR-mock’) served as control.
Ncr1
+/gfp C57BL/6 mice treated intratracheally with DTx (‘Het-tox’) or with PBS (‘Het-mock’) and Ncr1
gfp/gfp C57BL/6 mice treated with PBS (‘KO-mock’)
served as additional control groups. One day after DTx or mock treatment, all mice were challenged with 5610
7 CFU of S. pneumoniae strain WU2
and lungs were harvested 3 h after challenge. (A) CFU of S. pneumoniae in lungs, 3 h after bacterial challenge (n=3 to 5 per group). Results are
presented as box plot of CFU . *** p,0.001 compared with DTR-mock; ** p,0.01, compared with Het-mock, 6 SD (ANOVA test). (B) Flow cytometry
analysis of lung cells for CD11c and CD11b expression, 3 h after bacterial challenge (representative mouse). Numbers indicate percentage of gated
cells from total white blood cells. Results are from one representative experiment of two.
doi:10.1371/journal.pone.0023472.g005
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was not observed for the staining with mNKG2D-Ig. Macrophages
from lung, BM and spleen did not manifest heterogeneous
phenotype for NKG2D-ligands expression which did not differ
between Ncr1
+/+, Ncr1
+/gfp and Ncr1
gfp/gfp (Fig. 7B, C and D). In
addition, we studied CD11c
+ DC in both BM and spleen. The
NCR1-ligand
high DC sub-population in BM and spleen (data not
shown) was low to negligible and did not differ significantly between
the mice groups (1.4% vs. 3.3%, Fig. 7G). These results show, for
the first time, a unique macrophage sub-population, located in BM
and lung, which is characterized by high expression of ligands for
NCR1.
NCR1 contribution to activation of alveolar macrophages
We further investigated the NCR1 involvement in the activation
of naı ¨ve alveolar macrophages. Macrophage activation state can
be determined by (i) up regulation of activation molecules and by
(ii) phagocytic capacity. BALF cells were taken from Ncr1
+/+ or
Ncr1
gfp/gfp C57BL/6 mice lungs and the alveolar macrophages
were gated by staining with antibodies to CD45 and F4/80 and
analyzed for the expression of CD11b activation markers.
CD45
+F4/80
+ cells consisted the majority of BALF cells for both
Ncr1
+/+ and Ncr1
gfp/gfp mice types (97% and 96% respectively,
Fig. 8A). Higher fraction of CD11b
+ alveolar macrophages was
observed in Ncr1
+/+ compared to Ncr1
gfp/gfp mice (6% vs. 2.5%,
Fig. 8B). Macrophages number in the BALF was similar between
the Ncr1
+/gfp and Ncr1
gfp/gfp mice group as determined by cell
counting (403,333 vs. 487,667 per lung; data not shown).
Phagocytic capacity was evaluated by the incubation of CFDA-
stained bacteria with freshly isolated BALF cells and direct
visualization with either conventional fluorescent or confocal
microscope. We observed that significantly higher numbers of
BALF cells from Ncr1
+/+ mice were associated with CFDA-stained
bacteria as compared to BALF cells from Ncr1
gfp/gfp mice (2.2 fold,
p,0.05, Fig. 8C). Confocal-based analysis of WT BALF cells
showed that F4/80
+ cells were either NCR1-ligand
high or NCR1-
ligand
none (Fig. 8D, representative image). The ratio between the
two populations (0.3 vs. 1, p,0.01, Fig. 8E) was similar to the
results obtained by flow cytometry (Fig. 7E). The NCR1-ligand
dull
observed by flow cytometry parallel to the NCR1-ligand
none
observed by confocal microscopy. Importantly, there was a
significantly higher proportion of phagocytosed CFDA-stained
bacteria in F4/80
+/NCR1-ligand
high as compared to F4/80
+/
NCR1-ligand
none (2.6 fold, p,0.05, Fig. 8E). These results imply
that high NCR1 ligand expression is correlated with enhanced
phagocytic activity of macrophages and further support our
assumption that NCR1 expression by NK cells is associated with
priming of alveolar macrophages.
Figure 6. NCR1 involvement in NK cells activation following infection of BMMQ/ BMDC with S. pneumoniae. (A-D) Six-day culture of
BMMQ and BMDC grown from Ncr1
+/+ BM cells (C57BL/6) were stained with mNCR1-Ig, mNKG2D-Ig and LIR1-Ig fusion proteins. Shown are
representative overlays of F4/80
+CD115
+ BMMQ (A, C) and CD11c
+ BMDC (B, D) demonstrating staining with mNCR1-Ig (solid line, A-D), mNKG2D-Ig
(dotted line, C–D), LIR1-Ig (dashed line, A–B) and with goat anti-human IgG (grey-filled, A–D). Shown is one representative experiment out of four to
five independent experiments. In some experiments, NKG2D-Ig staining was higher compared to NCR1-Ig staining. (E–F) Six-day culture- BMMQ (E)
and -BMDC (F) grown from Ncr1
+/+ BM cells (C57BL/6) were infected with 1 MOI of S. pneumoniae for 1.5 h, then bacteria were removed and
antibiotics were added. In parallel, NK cells were isolated from splenocytes of Ncr1
+/+ (‘NK WT’) and Ncr1
gfp/gfp (‘NK KO’) C57BL/6 mice. Isolated NK
were incubated with uninfected BMMQ or BMDC, or with S. pneumoniae-infected BMMQ or BMDC (‘BMMQ+SP’, ‘BMDC+SP’) after removal of bacteria
for additional 18 hours. NK-BMMQ ratio was 1:4 and NK-BMDC ration was 1:10. IFNc concentration levels in the co-culture supernatants were
determined by ELISA. Results are from one representative experiment out of two. ** p,0.01 compared with IFNc levels of NK WT incubated with
infected BMMQ/BMDC, 6 SD (ANOVA test).
doi:10.1371/journal.pone.0023472.g006
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NK cells constitute a key frontline defense against a range of
viruses and bacteria. Different studies have demonstrated the
importance of NK cells in controlling bacterial infections in mice,
in particular with Shigella flexneri [32]. Human NKp46 is a key NK
activating receptor that was reported to be involved in the
response against Mycobacterium tuberculosis [14]. In the current study,
we investigated the involvement of the mouse NCR1 (murine
NKp46) in the innate immune response to S. pneumoniae infection.
We showed the following: (i) NCR1 receptor plays a role in S.
pneumoniae induced mortality in mice only when high challenge
doses are applied (Fig. 1); yet NCR1 plays an imperative role in
reducing S. pneumoniae bacterial load in the lungs at early stages
after infection. (Fig. 2); (ii) In vivo, NCR1 expression activates IFNc
production in the lung and enhances the expression on lung NK of
the membrane-associated CD107a early after infection with S.
pneumoniae (Fig. 3); (iii) In vivo, NK cells, lung macrophages and/or
DC are imperative for early clearance of S. pneumoniae (Fig. 4, 5);
(iv) In vitro, NCR1 is important for NK cells activation during the
interaction with S. pneumoniae-infected BMMQ and BMDC (Fig. 6);
(v) NCR1 presence in mice is directly correlated with the
magnitude of NCR1-ligand
high macrophage sub-population,
located in lungs and BM (Fig. 7); and (vi) NCR1 presence in
Figure 7. NCR1 ligand expression on S. pneumoniae and naı ¨ve macrophages and DC. (A) Fixed bacteria were stained with mNCR1-Ig (left
panel) and mNKG2D-Ig (right panel) fusion proteins. Shown are representative overlays of demonstrating staining with the fusion protein (bold line)
and with goat anti-human IgG (plain line). Both lines overlapped. Cells from lung lavage (B, E, F), BM (C, E, F, G) and spleen (D) of C57BL/6 Ncr1
+/+ (WT),
Ncr1
+/gfp (Het) and Ncr1
gfp/gfp (KO) naive mice were stained with mNCR1-Ig, mNKG2D-Ig, LIR1-Ig (B) or CD99-Ig (C, D) and with macrophages/DC
markers (F4/80, CD115, CD11c). Panels B-F were gated on macrophages (F4/80
+CD115
+) and panel G was gated on DC (CD11c
+). Panels B-D show
overlays of mNCR1-Ig staining as follows: bold line for Ncr1
+/+ (B1, C1, D1) or Ncr1
gfp/gfp (B2, C2, D2), hairline for Ncr1
+/gfp (C1, D1); LIR1-Ig staining
(grey line for B1, B2); CD99-Ig staining (dashed line for C1, C2, D1, D2); and goat anti-human IgG (grey line for B3, C3, D3). mNKG2D-Ig staining for all
mice types is shown is the right panel (B3, C3 and D3: Ncr1
+/+ in bold line, Ncr1
+/gfp in dashed line and Ncr1
gfp/gfp in dotted line). The bar graphs (E–G)
show the fraction of NCR1-ligand
high BAL and BM-gated macrophages for Ncr1
+/+ vs. Ncr1
gfp/gfp (E), the fraction of NCR1-ligand
high BAL and BM-gated
macrophages for Ncr1
+/gfp vs. Ncr1
gfp/gfp (F) and NCR1-ligand
high BM-gated DC (G). Results in E are normalized to Ncr1
+/+ (n=12 and 16 mice per
group). Results in F are normalized to Ncr1
+/gfp (n=12 and 15 mice per group). *** p,0.001 and * p,0.05 compared to WT/Het group +SD (two-
tailed student t-test). NS, non significant compared to WT/Het group. Results (B–D) are from one representative experiment out of six to seven.
doi:10.1371/journal.pone.0023472.g007
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capacity of alveolar macrophages (Fig. 8). Taken together, these
findings suggest that NCR1 plays an important role in mediating
the killing of S. pneumoniae in the lungs during the initial stages of
infection.
We studied survival rate following S. pneumoniae infection of
Ncr1
gfp/gfp, Ncr1
+/gfp and Ncr1
+/+ C57BL/6 mice. Deficiency of the
key NK activating receptor, NCR1, resulted in lower survival rate
of mice infected with high lethal dose. Lower lethal doses did not
induce differences in survival rate; yet, during the first 6 hours of
infection, a significantly reduced bacterial load was observed in the
lungs of Ncr1
+/+ and Ncr1
+/gfp mice compared to Ncr1
gfp/gfp mice.
In accordance with the survival results following lower lethal doses
challenge, 24 h after inoculation, bacterial load in the lungs of
Ncr1
gfp/gfp mice was comparable to the levels observed in the lungs
of Ncr1
+/+ and Ncr1
+/gfp mice. These results suggest that the NCR1
receptor plays an important role in mediating the clearance of S.
pneumoniae in the lungs only during the initial stages of infection. In
the late stages of infection, the intense inflammatory response that
evolves as a result of the large number of bacteria in the lungs may
conceal the NCR1 receptor effect. Alternatively, since inflamma-
tion contribute to S. pneumoniae proliferation in lungs [1,33] and
NK cell activity and IFNc could enhance inflammation [11], the
lesser contribution of NCR1-deficient NK cells to inflammation
Figure 8. NCR1 contribution to activation of naı ¨ve alveolar macrophages. BALF cells were harvested from Ncr1
+/+ and Ncr1
gfp/gfp naı ¨ve
C57BL/6 lungs. Alveolar macrophages were gated by staining with mAbs to CD45 and F4/80 (A) and gated cells were analyzed for the expression of
CD11b (B) by flow cytometry. Numbers indicate percentage of alveolar macrophages in BALF (A) and fraction of CD11b positive alveolar
macrophages (B). Results are from one representative experiment of five. (C) BALF cells taken from NCR1
+/+ (WT) and NCR1
gfp/gfp (KO) mice were
incubated with 1 MOI CFDA-labeled S. pneumonia for 2 h. Cells were then washed and visualized with a fluorescent microscope. The bar graph (C)
shows the average of fluorescent BALF cells (bac positive) from 11 microscopic fields. Numbers were normalized to the average of fluorescent BALF
cells from NCR1
gfp/gfp mice, which was considered as 1. *p,0.05 compared to NCR1
+/+ group, +SD (ANOVA test). Results are from one representative
experiment out of two. (D–E) Ncr1
+/+ BALF were incubated with 1 MOI CFDA-labeled S. pneumonia for 1 hr. Following wash of bacteria, cells were
fixed and stained with mNCR1-Ig and biotin-conjugated-rat anti mouse F4/80. Secondary staining was performed using APC-conjugated-F(ab’)2 goat-
anti-human-IgG-Fc and PE-Cy7-Strepavidin. Hoechst 33342 was employed for nuclear staining. Cells were washed and visualized with Confocal
microscope. (D) Representative confocal image of NCR1-ligand
high (bac positive) and NCR1-ligand
none (bac negative) macrophages (F4/80 staining is
not shown) (magnification X400). (E) We analyzed 52 random fields from 6 independent experiments and counted F4/80
+ NCR1-ligand
high and NCR1-
ligand
none cells, either positive or not for bacteria. The average number of NCR1-ligand
high and NCR1-ligand
none is shown normalized to NCR1-
ligand
none, which its average was considered as 1. (left two columns of the graph, **p,0.01 compared to NCR1-ligand
high group, +SD (two-tailed
student t-test)). We then calculated the ratio of bacteria-positive for each of the two populations and normalized the results according to the fraction
of NCR1-ligand
none&bac+ of the total NCR1-ligand
none cells. Right two columns of graph shows the normalized fraction of bacteria positive cells for the
two macrophage populations (NCR1-ligand
high and NCR1-ligand
none). *p,0.05 compared to NCR1-ligand
high group, +SD (two-tailed student t-test).
doi:10.1371/journal.pone.0023472.g008
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in accordance with the report on the detrimental effect of NK cells
in S. pneumoniae infection [26]. The plausible divergent contribu-
tion of NCR1-mediated IFNc production at early stages (clearance
of S. pneumoniae) and late stages (enhancement of inflammation)
could also explain the contradictory reports on the role of IFNc in
response to S. pneumoniae [10-12].
No differences in the bacterial load and survival between the
Ncr1
+/+ and the Ncr1
+/gfp mice could be observed. This was in
accordance with a previous study, which demonstrated that NK
cells from Ncr1
+/gfp mice are fully functional while NK cells from
Ncr1
gfp/gfp mice manifest reduced activity following influenza
infection and tumor development [25]. The reduced bacterial load
in the Ncr1
+/+ and Ncr1
+/gfp mice suggested that the NK cell were
activated via NCR1 following infection. To evaluate the extent of
NK cell activation we investigated the expression of CD107a and
IFNc production following bacterial challenge. CD107a expres-
sion on NK cell membrane represents the fusion of secretory
granules with the plasma membrane and characterize early stages
of NK cell activation [29]. Three hours following inoculation of
mice enhancement of CD107a expression on NCR1-expressing
NK cells was higher than that found on NCR1-deficient NK cells
(Fig. 3A). In accordance with the CD107a levels, 3h following
infection the IFNc transcript level in the lungs was significantly
higher in Ncr1
+/gfp mice compared to Ncr1
gfp/gfp infected mice
(Fig. 3B). In contrast, 3h following infection, TNFa and IL-6
transcripts in the lungs of Ncr1
gfp/gfp mice were significantly higher
compared to the transcripts of these cytokines in Ncr1
+/gfp mice
(Fig. 3C, D). This could be explained by the significantly higher
bacterial load in Ncr1
gfp/gfp mice 3h after infection (Fig. 2A).
Indeed, we did not observe this result for TNFa and IL-6 in the in
vitro assays (data not shown) since S. pneumoniae was removed after
1.5 hrs and antibiotics were added.
A recent study suggested that NKp44 may be involved in the
direct recognition of bacteria [31]. To investigate the possibility of
direct recognition of the bacterium by NCR1 receptor, we stained
S. pneumoniae with soluble mNCR1-Ig and mNKG2D-Ig fusion
proteins (Fig. 7A). Our results suggest the absence of NCR1
ligands on S. pneumoniae and thus preclude NCR1-mediated direct
recognition of the bacteria by NK cells. However, these results
suggest that the enhanced S. pneumoniae clearance may be mediated
by innate immune accessory cells. The first immune cells to
encounter the bacteria are the lung macrophages and DC [2]. To
investigate macrophages and DC involvement in the S. pneumoniae
clearance at early stages following infection we compared the
bacterial load level of S. pneumoniae in Ncr1
gfp/gfp, Ncr1
+/gfp mice
and in DTR:CD11c transgenic mice in which the lung
mononuclear phagocytes including alveolar macrophages were
ablated (Fig. 5). Our findings suggests that (i) the presence of
macrophages and dendritic cells in the lungs is imperative for early
clearance S. pneumoniae; (ii) the lack of lung mononuclear
phagocytes and the absence of NK-expressed Ncr1 result in the
same bacterial load level. Our findings are supported by Sun et al.
who demonstrated that the resident alveolar macrophages bind S.
pneumoniae within 4 hours and their depletion with liposomal
clodronate led to enhanced bacterial outgrowth in both lung
tissues and alveoli [34]. We then searched for the existence of
NCR1 receptor ligands on BMMQ and BMDC. Using the
mNCR-Ig fusion protein we have found that BMMQ and BMDC
express ligands for NCR1 receptor as well as ligands for
mNKG2D receptor (Fig. 6A–D). Next we investigated whether
the cross talk between NK cells and S. pneumoniae infected
macrophages and DC is mediated through NCR1 by assessing
the extent of IFNc production. Supernatants of S. pneumoniae
infected BMMQ and BMDC co-cultured with NK cells showed
enhanced IFNc levels in an NK-NCR1-dependent manner
(Fig. 6E–F). We further demonstrated that upon challenge with
S. pneumoniae, BMDC up-regulate their co stimulatory molecules
(data not shown). This up-regulation was previously demonstrated
to be useful for their interaction with NK cells which then
improves the immune response against bacterial infections [35,36].
Together these results imply the importance of the cross talk
between DC, macrophages and NK cells following infection with
S. pneumoniae in vitro. According to Ferlazzo et al., the biological
relevance of NK cell activation mediated by DCs during bacterial
infections resides mainly in the secretion of IFNc [36]. The higher
secretion of IFNc found in our study in vitro and in vivo in the Ncr1
+/
+ mice may result also from the improved NK-DC/macrophage
cross talk which in turn augments bacterial clearance by the DC/
macrophages. Our results suggest that NK-expressed NCR1 is
mediating a direct cross talk between NK cells and macrophages/
DC which is contributing to S. pneumoniae clearance by macro-
phages and DC. Reciprocal activating interaction between NK
cells and DC was already reported for several bacterial pathogens
[35–37]. Yet, our results extend it to NK-macrophages interaction
for S. pneumoniae infection and point to the involvement of NK-
expressed NCR1 in this cross talk. To further assess the role of NK
cells and NCR1 in resistance to S. pneumoniae infection, NK cells
were depleted from Ncr1
gfp/gfp and Ncr1
+/+ mice using anti-asialo
GM1 and then challenged with S. pneumoniae (Fig. 4). In both
strains, depletion of NK cells prior to infection resulted in a
significant increased bacterial load 3 h following inoculation in
comparison to the mock-treated mice. Surprisingly, the bacterial
load level in the lungs of NK-depleted Ncr1
gfp/gfp mice was
significantly higher than in the NK-depleted Ncr1
+/+ mice. These
results suggest that in addition to NK cells contribution to the early
clearance of S. pneumoniae in the first 3 h, Ncr1
+/+ mice are better
conditioned to clear S. pneumoniae. Indeed, alveolar macrophages
from NCR1-positive mice were more potent than alveolar
macrophages from NCR1-deficient mice prior to any S. pneumoniae
infection (Fig. 8). This conditioning may occur in the lung prior to
infection and could indicate NCR1-mediated pathogen-indepen-
dent priming of lung macrophages by NK cells. Alternatively, it
could be the result of NCR1-mediated cross talk between NK cells
and lung macrophages in response to commensal pathogens.
Recently published studies [38,39] described that activation of NK
cells prior to infection resulted in macrophage priming, which
improved their microbial clearance abilities. We therefore
investigated the expression of NCR1 ligands on macrophages
and DCs. The results show, for the first time, a unique
macrophage sub-population, located in the BM and in the lungs,
which is characterized by a high expression of the NCR1 ligand
(Fig. 7, B–F). This population was significantly higher in
macrophages from Ncr1
+/+ and Ncr1
+/gfp mice compared to
Ncr1
gfp/gfp mice. We did not observe this correlation for DC
(Fig. 7G). This NCR1-ligand
high macrophage sub-population was
responsible for the better phagocytic activity of the NCR1-
exprsseing mice as it manifested efficient phagocytosis compared
to the NCR1-ligand
none macrophages (Fig. 8). Therefore, this
NCR1-ligand
high macrophage sub-population could be involved in
the conditioning/priming and/or activation of the macrophages
by NCR1-expressing NK cells in a cell-to-cell contact interaction
prior to infection and during the early phase of infection.
To summarize, we showed the involvement of NK cells and NK-
expressed NCR1 in the early clearance of S. pneumoniae and the
contribution of NCR1 to the cross talk of NK and macrophages/
DC. The plausible phenomenon of NK-NCR1-mediated pre-
conditioning of lung phagocytes and the NCR1-dependent
NCR1 Role in Streptococcus pneumoniae Clearance
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high macrophages should be further
explored.
Acknowledgments
Shirin Elhaik-Goldman is an ISEF scholar.
Author Contributions
Conceived and designed the experiments: AP YM-N. Performed the
experiments: SE-G DK LH AV-E HG. Analyzed the data: SE-G DK UH
ME HG AB. Contributed reagents/materials/analysis tools: RY SJ AB
RNA OM RD. Wrote the paper: SE-G AP.
References
1. Dagan R GD, Jacobs N (2004) Pneumococcal infections; Feigin R CJ, Demmler
GJ, Kaplan S, editor. philadelphias Saunders. pp 1204–1258.
2. Kadioglu A, Andrew PW (2004) The innate immune response to pneumococcal
lung infection: the untold story. Trends Immunol 25(3): 143–149.
3. McCool TL, Weiser JN (2004) Limited role of antibody in clearance of
Streptococcus pneumoniae in a murine model of colonization. Infect Immun
72(10): 5807–5813.
4. Zhang Z, Clarke TB, Weiser JN (2009) Cellular effectors mediating Th17-
dependent clearance of pneumococcal colonization in mice. J Clin Invest 119(7):
1899–1909.
5. Bogaert D, Weinberger D, Thompson C, Lipsitch M, Malley R (2009) Impaired
innate and adaptive immunity to Streptococcus pneumoniae and its effect on
colonization in an infant mouse model. Infect Immun 77(4): 1613–1622.
6. Bogaert D, De Groot R, Hermans PW (2004) Streptococcus pneumoniae
colonisation: the key to pneumococcal disease. Lancet Infect Dis 4(3): 144–154.
7. van der Poll T, Keogh CV, Buurman WA, Lowry SF (1997) Passive
immunization against tumor necrosis factor-alpha impairs host defense during
pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155(2):
603–608.
8. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, et al. (1997)
Interleukin-6 gene-deficient mice show impaired defense against pneumococcal
pneumonia. J Infect Dis 176(2): 439–444.
9. Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, et al. (2008)
Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int
Immunol 20(9): 1139–1146.
10. Rubins JB, Pomeroy C (1997) Role of gamma interferon in the pathogenesis of
bacteremic pneumococcal pneumonia. Infect Immun 65(7): 2975–2977.
11. Rijneveld AW, Lauw FN, Schultz MJ, Florquin S, Te Velde AA, et al. (2002)
The role of interferon-gamma in murine pneumococcal pneumonia. J Infect Dis
185(1): 91–97.
12. Schultz MJ, Rijneveld AW, Speelman P, van Deventer SJ, van der Poll T (2001)
Endogenous interferon-gamma impairs bacterial clearance from lungs during
Pseudomonas aeruginosa pneumonia. Eur Cytokine Netw 12(1): 39–44.
13. Yokoyama WM, Kim S, French AR (2004) The dynamic life of natural killer
cells. Annu Rev Immunol 22: 405–429.
14. Garg A, Barnes PF, Porgador A, Roy S, Wu S, et al. (2006) Vimentin expressed
on Mycobacterium tuberculosis-infected human monocytes is involved in
binding to the NKp46 receptor. J Immunol 177(9): 6192–6198.
15. Warfield KL, Perkins JG, Swenson DL, Deal EM, Bosio CM, et al. (2004) Role
of natural killer cells in innate protection against lethal ebola virus infection.
J Exp Med 200(2): 169–179.
16. Weiss L, Reich S, Mandelboim O, Slavin S (2004) Murine B-cell leukemia
lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy. Bone
Marrow Transplant 33(11): 1137–1141.
17. Dunn PL, North RJ (1991) Early gamma interferon production by natural killer
cells is important in defense against murine listeriosis. Infect Immun 59(9):
2892–2900.
18. Kawakami K, Yamamoto N, Kinjo Y, Miyagi K, Nakasone C, et al. (2003)
Critical role of Valpha14+ natural killer T cells in the innate phase of host
protection against Streptococcus pneumoniae infection. Eur J Immunol 33(12):
3322–3330.
19. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, et al. (1998) Molecular
cloning of NKp46: a novel member of the immunoglobulin superfamily involved
in triggering of natural cytotoxicity. J Exp Med 188(5): 953–960.
20. Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, et al. (1999) The murine
homologue of the human NKp46, a triggering receptor involved in the induction
of natural cytotoxicity. Eur J Immunol 29(3): 1014–1020.
21. Mandelboim O, Porgador A (2001) NKp46. Int J Biochem Cell Biol 33(12):
1147–1150.
22. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, et al. (1999) NKp46 is
the major triggering receptor involved in the natural cytotoxicity of fresh or
cultured human NK cells. Correlation between surface density of NKp46 and
natural cytotoxicity against autologous, allogeneic or xenogeneic target cells.
Eur J Immunol 29(5): 1656–1666.
23. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001)
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis
by human NK cells. Nature 409(6823): 1055–1060.
24. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, et al. (2001) Recognition
of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31(9):
2680–2689.
25. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza
infection in the absence of the natural killer cell receptor gene Ncr1. Nat
Immunol 7(5): 517–523.
26. Kerr AR, Kirkham LA, Kadioglu A, Andrew PW, Garside P, et al. (2005)
Identification of a detrimental role for NK cells in pneumococcal pneumonia
and sepsis in immunocompromised hosts. Microbes Infect 7(5-6): 845–852.
27. Landsman L, Jung S (2007) Lung macrophages serve as obligatory intermediate
between blood monocytes and alveolar macrophages. J Immunol 179(6):
3488–3494.
28. Briles DE, Nahm M, Schroer K, Davie J, Baker P, et al. (1981) Antipho-
sphocholine antibodies found in normal mouse serum are protective against
intravenous infection with type 3 streptococcus pneumoniae. J Exp Med 153(3):
694–705.
29. Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the
identification of natural killer cell activity. J Immunol Methods 294(1-2): 15–22.
30. Blue CE, Paterson GK, Kerr AR, Berge M, Claverys JP, et al. (2003) ZmpB, a
novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis
factor alpha production in the respiratory tract. Infect Immun 71(9): 4925–4935.
31. Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, et al. (2008)
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the
surfaces of mycobacteria and other bacteria. Infect Immun 76(4): 1719–1727.
32. Le-Barillec K, Magalhaes JG, Corcuff E, Thuizat A, Sansonetti PJ, et al. (2005)
Roles for T and NK cells in the innate immune response to Shigella flexneri.
J Immunol 175(3): 1735–1740.
33. Cundell D, Masure HR, Tuomanen EI (1995) The molecular basis of
pneumococcal infection: a hypothesis. Clin Infect Dis 21(Suppl 3): S204–211.
34. Sun K, Metzger DW (2008) Inhibition of pulmonary antibacterial defense by
interferon-gamma during recovery from influenza infection. Nat Med 14(5):
558–564.
35. Colino J, Shen Y, Snapper CM (2002) Dendritic cells pulsed with intact
Streptococcus pneumoniae elicit both protein- and polysaccharide-specific
immunoglobulin isotype responses in vivo through distinct mechanisms. J Exp
Med 195(1): 1–13.
36. Ferlazzo G, Morandi B, D’Agostino A, Meazza R, Melioli G, et al. (2003) The
interaction between NK cells and dendritic cells in bacterial infections results in
rapid induction of NK cell activation and in the lysis of uninfected dendritic cells.
Eur J Immunol 33(2): 306–313.
37. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, et al. (2002)
Reciprocal activating interaction between natural killer cells and dendritic cells.
J Exp Med 195(3): 327–333.
38. Gaforio JJ, Ortega E, Algarra I, Serrano MJ, Alvarez de Cienfuegos G (2002)
NK cells mediate increase of phagocytic activity but not of proinflammatory
cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12)
production elicited in splenic macrophages by tilorone treatment of mice during
acute systemic candidiasis. Clin Diagn Lab Immunol 9(6): 1282–1294.
39. Scott MJ, Hoth JJ, Gardner SA, Peyton JC, Cheadle WG (2003) Natural killer
cell activation primes macrophages to clear bacterial infection. Am Surg 69(8):
679–686; discussion686-677.
NCR1 Role in Streptococcus pneumoniae Clearance
PLoS ONE | www.plosone.org 12 August 2011 | Volume 6 | Issue 8 | e23472